What does CUSIP 45408X308 represent in this 13F holders report?

CUSIP 45408X308 is the security identifier for IGC - IGC Pharma, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held IGC - IGC Pharma, Inc. - COM NEW in Q2 2023?

22 institutional investors reported IGC - IGC Pharma, Inc. - COM NEW for Q2 2023. Use the holders table for investor-level position and value details.

IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / COM NEW
Total 13F shares: 2,653,184
Share change: -51,931
Total reported value: $827,470
Put/Call ratio: 42%
Price per share: $0.31
Number of holders: 22
Value change: -$16,523
Number of buys: 5
Number of sells: 6

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 45408X308:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	— class O/S missing	755,862	$256,616	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	646,543	$219,501	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	302,140	$102,576	—	31 Mar 2023	13F
Rohit Goel	3/4/5	Senior Director of Finance&PAO	— class O/S missing	235,000	$79,900	—	13 May 2021	3/4/5
STATE STREET CORP	13F	Company	— class O/S missing	184,107	$62,504	—	31 Mar 2023	13F
John E. Lynch	3/4/5	Director	— mixed-class rows	396,901 mixed-class rows	$45,696	—	31 May 2022	3/4/5
DEARBORN PARTNERS LLC	13F	Company	— class O/S missing	116,710	$39,623	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	110,300	$37,000	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	103,783	$35,000	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	88,722	$30,121	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	71,364	$24,228	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	69,000	$23,426	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	65,503	$22,238	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	— class O/S missing	60,156	$20,423	—	31 Mar 2023	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	— class O/S missing	53,156	$18,000	—	31 Mar 2023	13F
TRUIST FINANCIAL CORP	13F	Company	— class O/S missing	36,667	$12,448	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	20,795	$7,000	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	— class O/S missing	15,610	$5,300	—	31 Mar 2023	13F
Geneos Wealth Management Inc.	13F	Company	— class O/S missing	3,000	$1,020	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	— class O/S missing	810	$275	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	341	$116	—	31 Mar 2023	13F
UBS Group AG	13F	Company	— class O/S missing	294	$100	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	232	$78	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	20	$7	—	31 Mar 2023	13F

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2023

As of 30 Jun 2023, IGC Pharma, Inc. - COM NEW (IGC) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,653,184 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DEARBORN PARTNERS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.